Literature DB >> 19810012

Severe iron overload in Blackfan-Diamond anemia: a case-control study.

Simona Roggero1, Paola Quarello, Tiziana Vinciguerra, Filomena Longo, Antonio Piga, Ugo Ramenghi.   

Abstract

Chronic iron overload is a serious complication in transfusion-dependent patients. Few studies have addressed this issue in Diamond-Blackfan anemia (DBA). We describe a retrospective analysis of iron overload, and its related complications in 31 transfusion-dependent Italian DBA patients whose records included one or more evaluation of liver iron concentration (LIC) by means of noninvasive magnetic liver susceptometry with a superconductive quantum interference device (SQUID). This cohort is also matched with a group of transfusion-dependent beta-thalassemia major patients to look for differences. A severe iron overload was observed in 54% patients, especially among those inadequately chelated. The DBA patients displayed a significantly higher LIC than the regularly chelated beta-thalassemics. This difference may have been attributable to nonoptimal chelation (late onset, type, dose, prescription, and compliance), or an unknown biological mechanism that lead to an early severe iron overload. We therefore suggest that all transfusion patients should have an accurate record of their iron intake, a regular monitoring of iron overload, in order to start chelation when a critical transfusion load is reached, and to test the efficacy/compliance of chelation treatment. Physicians taking care of transfusion-dependent DBA patients must be concerned about the frequent and early complications such as cardiac toxicity. Am. J. Hematol., 2009. (c) 2009 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2009        PMID: 19810012     DOI: 10.1002/ajh.21541

Source DB:  PubMed          Journal:  Am J Hematol        ISSN: 0361-8609            Impact factor:   10.047


  20 in total

Review 1.  Neonatal manifestations of inherited bone marrow failure syndromes.

Authors:  Payal P Khincha; Sharon A Savage
Journal:  Semin Fetal Neonatal Med       Date:  2015-12-24       Impact factor: 3.926

2.  L-Leucine improves the anemia and developmental defects associated with Diamond-Blackfan anemia and del(5q) MDS by activating the mTOR pathway.

Authors:  Elspeth M Payne; Maria Virgilio; Anupama Narla; Hong Sun; Michelle Levine; Barry H Paw; Nancy Berliner; A Thomas Look; Benjamin L Ebert; Arati Khanna-Gupta
Journal:  Blood       Date:  2012-06-25       Impact factor: 22.113

Review 3.  Late Effects Screening Guidelines after Hematopoietic Cell Transplantation for Inherited Bone Marrow Failure Syndromes: Consensus Statement From the Second Pediatric Blood and Marrow Transplant Consortium International Conference on Late Effects After Pediatric HCT.

Authors:  Andrew C Dietz; Sharon A Savage; Adrianna Vlachos; Parinda A Mehta; Dorine Bresters; Jakub Tolar; Carmem Bonfim; Jean Hugues Dalle; Josu de la Fuente; Roderick Skinner; Farid Boulad; Christine N Duncan; K Scott Baker; Michael A Pulsipher; Jeffrey M Lipton; John E Wagner; Blanche P Alter
Journal:  Biol Blood Marrow Transplant       Date:  2017-05-19       Impact factor: 5.742

Review 4.  How I treat Diamond-Blackfan anemia.

Authors:  Adrianna Vlachos; Ellen Muir
Journal:  Blood       Date:  2010-07-22       Impact factor: 22.113

Review 5.  Current Knowledge and Priorities for Future Research in Late Effects after Hematopoietic Cell Transplantation for Inherited Bone Marrow Failure Syndromes: Consensus Statement from the Second Pediatric Blood and Marrow Transplant Consortium International Conference on Late Effects after Pediatric Hematopoietic Cell Transplantation.

Authors:  Andrew C Dietz; Parinda A Mehta; Adrianna Vlachos; Sharon A Savage; Dorine Bresters; Jakub Tolar; Farid Boulad; Jean Hugues Dalle; Carmem Bonfim; Josu de la Fuente; Christine N Duncan; K Scott Baker; Michael A Pulsipher; Jeffrey M Lipton; John E Wagner; Blanche P Alter
Journal:  Biol Blood Marrow Transplant       Date:  2017-01-20       Impact factor: 5.742

Review 6.  Pathophysiology and management of inherited bone marrow failure syndromes.

Authors:  Akiko Shimamura; Blanche P Alter
Journal:  Blood Rev       Date:  2010-04-24       Impact factor: 8.250

7.  Endocrine Dysfunction in Diamond-Blackfan Anemia (DBA): A Report from the DBA Registry (DBAR).

Authors:  Amit Lahoti; Yael T Harris; Phyllis W Speiser; Evangelia Atsidaftos; Jeffrey M Lipton; Adrianna Vlachos
Journal:  Pediatr Blood Cancer       Date:  2015-10-23       Impact factor: 3.167

Review 8.  Diamond Blackfan anemia 2008-2009: broadening the scope of ribosome biogenesis disorders.

Authors:  Jeffrey M Lipton; Steven R Ellis
Journal:  Curr Opin Pediatr       Date:  2010-02       Impact factor: 2.856

Review 9.  Critical Issues in Diamond-Blackfan Anemia and Prospects for Novel Treatment.

Authors:  Hojun Li; Harvey F Lodish; Colin A Sieff
Journal:  Hematol Oncol Clin North Am       Date:  2018-06-05       Impact factor: 3.722

10.  Atypical erythroblastosis in a patient with Diamond-Blackfan anemia who developed del(20q) myelodysplasia.

Authors:  Motoshi Sonoda; Masataka Ishimura; Yuko Ichimiya; Eiko Terashi; Katsuhide Eguchi; Yasunari Sakai; Hidetoshi Takada; Asahito Hama; Hitoshi Kanno; Tsutomu Toki; Etsuro Ito; Shouichi Ohga
Journal:  Int J Hematol       Date:  2018-02-23       Impact factor: 2.490

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.